Literature DB >> 12021955

14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis.

Jérôme de Seze, Katel Peoc'h, Didier Ferriby, Tanya Stojkovic, Jean-Louis Laplanche, Patrick Vermersch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12021955     DOI： 10.1007/s004150200074

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  12 in total

1.  14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis.

Authors:  D N Irani; D A Kerr
Journal:  Lancet       Date:  2000-03-11       Impact factor: 79.321

Review 2.  14-3-3 proteins: structure, function, and regulation.

Authors:  H Fu; R R Subramanian; S C Masters
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

3.  14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis.

Authors:  A Martínez-Yélamos; A Saiz; R Sanchez-Valle; V Casado; J M Ramón; F Graus; T Arbizu
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

4.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Pocchiari; S Collins; J P Brandel; J de Pedro Cuesta; R S Knight; H Bernheimer; F Cardone; N Delasnerie-Lauprêtre; N Cuadrado Corrales; A Ladogana; M Bodemer; A Fletcher; T Awan; A Ruiz Bremón; H Budka; J L Laplanche; R G Will; S Poser
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

5.  CSF detection of the 14-3-3 protein in unselected patients with dementia.

Authors:  P R Burkhard; J C Sanchez ; T Landis; D F Hochstrasser
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

6.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

7.  Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders

Authors: 
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

8.  Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Authors:  C Bjartmar; G Kidd; S Mörk; R Rudick; B D Trapp
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

9.  14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Authors:  P Beaudry; P Cohen; J P Brandel; N Delasnerie-Lauprêtre; S Richard; J M Launay; J L Laplanche
Journal:  Dement Geriatr Cogn Disord       Date:  1999 Jan-Feb       Impact factor: 2.959

10.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910
View more
  5 in total

Review 1.  14-3-3s are potential biomarkers for HIV-related neurodegeneration.

Authors:  Diana Morales; Efthimios C M Skoulakis; Summer F Acevedo
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

Review 2.  Current and Future Biomarkers in Multiple Sclerosis.

Authors:  Jennifer Yang; Maysa Hamade; Qi Wu; Qin Wang; Robert Axtell; Shailendra Giri; Yang Mao-Draayer
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

3.  Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.

Authors:  Irena Dujmovic
Journal:  Mult Scler Int       Date:  2011-05-02

4.  Proteomic and bioinformatic analyses of spinal cord injury‑induced skeletal muscle atrophy in rats.

Authors:  Zhi-Jian Wei; Xian-Hu Zhou; Bao-You Fan; Wei Lin; Yi-Ming Ren; Shi-Qing Feng
Journal:  Mol Med Rep       Date:  2016-05-13       Impact factor: 2.952

Review 5.  Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.

Authors:  Alberto Gajofatto; Massimiliano Calabrese; Maria Donata Benedetti; Salvatore Monaco
Journal:  Dis Markers       Date:  2013-11-10       Impact factor: 3.434
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.